BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24477605)

  • 1. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):631-7. PubMed ID: 24477605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3611-6. PubMed ID: 24310505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3125-32. PubMed ID: 24254307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3327-31. PubMed ID: 24272203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer.
    Didem T; Faruk T; Senem K; Derya D; Murat S; Murat G; Oznur K
    Tumour Biol; 2014 Jul; 35(7):6777-82. PubMed ID: 24722824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3095-102. PubMed ID: 24307621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
    Pylväs-Eerola M; Karihtala P; Puistola U
    BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
    Yildiz I; Tas F; Kilic L; Sen F; Saip P; Eralp Y; Keskin S; Karabulut S; Ciftci R; Serilmez M; Yasasever V; Aydiner A
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):437-44. PubMed ID: 23801282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?
    Karabulut S; Akşit E; Tas F; Ciftci R; Aydiner A; Yildiz I; Keskin S; Eralp Y; Yasasever CT; Vatansever S; Disci R; Saip P
    Tumour Biol; 2014 May; 35(5):4323-9. PubMed ID: 24390664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
    Luo Y; Kim HS; Kim M; Lee M; Song YS
    J Gynecol Oncol; 2017 May; 28(3):e36. PubMed ID: 28382799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
    Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR
    Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
    Tas F; Bilgin E; Karabulut S; Duranyildiz D
    Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer.
    Lee M; Chang MY; Yoo H; Lee KE; Chay DB; Cho H; Kim S; Kim YT; Kim JH
    Yonsei Med J; 2016 May; 57(3):580-7. PubMed ID: 26996555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
    Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
    J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.
    Tas F; Kilic L; Bilgin E; Keskin S; Sen F; Ciftci R; Yildiz I; Yasasever V
    Int J Gynecol Cancer; 2013 Feb; 23(2):276-81. PubMed ID: 23266651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.